✔️ Summary: In this episode, Vivian Chen talks about her journey climbing the corporate ladder. In particular, she was able to successfully transition from a technical PhD scientist to a strategy and operations professional at a multinational pharmaceutical company. I find it especially fascinating her take on why the pharmaceutical industry may be better than the tech industry, at least for some people, including herself.

⭐️ About Vivian: Vivian is currently the Director of Portfolio and Strategy at AstraZeneca. Prior to AstraZeneca, Vivian was a Senior Consultant within Deloitte’s Supply Chain & Network Operations practice where she successfully advised, implemented, and operated business and digital transformations for life sciences clients. Her other professional accomplishments include eight years of project and product management experience working in the scientific instrumentation industry for corporations including Shimadzu Scientific Instruments, Agilent Technologies, and Bruker Daltonics. During her tenure she managed and supported product development of both custom software and hardware for pharmaceutical and biotech, clinical labs and hospitals, forensic labs, chemical and energy, environmental, consumer packaged goods (CPGs) and university clients. She has supported products and clients in 40+ states in the United States and 4 overseas countries, such as Spain, Germany, China, and Japan.